[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519037":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":31,"responsibleParty":92,"collaborators":19,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":19,"eligibilityCriteria":100,"healthyVolunteers":96,"sex":101,"minAge":102,"maxAge":103,"enrollmentInfo":104,"targetDuration":19,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":34,"whyStopped":19,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"TBF Genie Tissulaire","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SclerFIX-IP","EXPERIMENTAL","Treated, devitalised and sterile graft of umbilical cord amniotic membrane",[13],"Biological: SclerFIX-IP",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BIOLOGICAL","Decellularized, viro-inactivated, freeze-dried and sterile allogeneic graft of amniotic membrane of umbilical cord used as an interposition implant in the STT joint",[9],null,[21,27],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Laurence BARNOUIN, MD","CONTACT","4 72 68 69 09","+33","laurence.barnouin@tbf-lab.com",{"name":28,"role":23,"phone":29,"phoneExt":25,"email":30},"Justine BOSC, MSc","4 72 68 69 11","justine.bosc@tbf-lab.com",[32,50,64,77],{"facility":33,"status":34,"city":35,"state":19,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"CHU de Besançon","RECRUITING","Besançon","25030","France","FR",{"type":40,"coordinates":41},"Point",[42,43],6.01815,47.24878,{"lat":43,"lon":42},[46,48],{"name":47,"role":23,"phone":19,"phoneExt":19,"email":19},"François LOISEL, MD",{"name":47,"role":49,"phone":19,"phoneExt":19,"email":19},"PRINCIPAL_INVESTIGATOR",{"facility":51,"status":34,"city":52,"state":19,"zip":53,"country":37,"countryCode":38,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Institut Chirurgical de la Main et du Membre Supérieur (ICMMS)","Lyon","69006",{"type":40,"coordinates":55},[56,57],4.84789,45.74906,{"lat":57,"lon":56},[60,63],{"name":61,"role":23,"phone":19,"phoneExt":19,"email":62},"Lionel ERHARD, MD","lionel.erhard@institut-chirurgical.com",{"name":61,"role":49,"phone":19,"phoneExt":19,"email":19},{"facility":65,"status":34,"city":66,"state":19,"zip":67,"country":37,"countryCode":38,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Centre de la Main - Clinique Jules Verne","Nantes","44300",{"type":40,"coordinates":69},[70,71],-1.55336,47.21725,{"lat":71,"lon":70},[74,76],{"name":75,"role":23,"phone":19,"phoneExt":19,"email":19},"Edward de KEATING-HART, MD",{"name":75,"role":49,"phone":19,"phoneExt":19,"email":19},{"facility":78,"status":34,"city":79,"state":19,"zip":80,"country":37,"countryCode":38,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Hôpitaux Universitaires de Strasbourg","Strasbourg","67200",{"type":40,"coordinates":82},[83,84],7.74553,48.58392,{"lat":84,"lon":83},[87,89],{"name":88,"role":49,"phone":19,"phoneExt":19,"email":19},"Sybille FACCA, Professor",{"name":90,"role":91,"phone":19,"phoneExt":19,"email":19},"Kursat ERDOGAN, MD","SUB_INVESTIGATOR",{"type":93,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100519037","phase-2-use-of-a-treated-devitalized-and-sterile-umbilical-cord-amniotic-membrane-in-the-treatment-of-stt-osteoarthritis-100519037",false,"NCT06038331","Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis","Evaluation of the Treatment of Symptomatic Scaphotrapeziotrapezoidal (STT) Osteoarthritis With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition","Inclusion Criteria:\n\n* Male or female; age between 18 and 75 years.\n* Patient with symptomatic STT OA.\n* Patient treated medically for functional signs for more than 3 months, without improvement, justifying a surgical intervention.\n* Patient with a QuickDash score \\> 33 points (converted to 50%).\n* Patient with wrist pain in front of the STT joint at rest = or \\> 4\u002F10 on VAS.\n* Patient who received the study information and provided consent.\n* Member or beneficiary of a national health insurance plan.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding woman; woman without effective contraception.\n* Patient with functional rhizarthrosis that has not been stabilized or treated medically or surgically.\n* Patient with signs of neuropathy with functional disorders such as hyperesthesia.\n* Patient with uncontrolled epilepsy or neuropathy that contraindicates locoregional anesthesia.\n* Person confined by a judicial or administrative decision.\n* Adult subjected to legal protection measures or unable to provide his\u002Fher consent.","ALL","18 Years","75 Years",{"count":105,"type":106},14,"ESTIMATED","INTERVENTIONAL",[109],"PHASE2","The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of STT osteoarthritis.",[112],"Osteoarthritis Hand",[114],"ScaphoTrapezioTrapezoid OsteoArthritis (STT OA)","2025-09-24",{"date":117,"type":118},"2025-09-30","ACTUAL",{"date":120,"type":118},"2024-05-28",{"date":122,"type":106},"2026-12",{"name":5,"class":6},4]